AbbVie Inc. (BMV:ABBV)

DFS Statistics

Total Valuation

AbbVie has a market cap or net worth of MXN 6.48 trillion. The enterprise value is 7.67 trillion.

Market Cap	6.48T
Enterprise Value	7.67T

Important Dates

The last earnings date was Friday, July 25, 2025.

Earnings Date	Jul 25, 2025
Ex-Dividend Date	Jul 15, 2025

Share Statistics

Current Share Class	1.77B
Shares Outstanding	n/a
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	-0.06%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.76B

Valuation Ratios

The trailing PE ratio is 92.36 and the forward PE ratio is 14.97.

PE Ratio	92.36
Forward PE	14.97
PS Ratio	5.90
PB Ratio	-2,491.72
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.57, with an EV/FCF ratio of 22.31.

EV / Earnings	109.30
EV / Sales	7.10
EV / EBITDA	14.57
EV / EBIT	20.91
EV / FCF	22.31

Financial Position

The company has a current ratio of 0.74

Current Ratio	0.74
Quick Ratio	0.48
Debt / Equity	n/a
Debt / EBITDA	2.48
Debt / FCF	3.87
Interest Coverage	6.92

Financial Efficiency

Return on equity (ROE) is 112.85% and return on invested capital (ROIC) is 16.70%.

Return on Equity (ROE)	112.85%
Return on Assets (ROA)	8.87%
Return on Invested Capital (ROIC)	16.70%
Return on Capital Employed (ROCE)	20.33%
Revenue Per Employee	20.00M
Profits Per Employee	1.28M
Employee Count	55,000
Asset Turnover	0.42
Inventory Turnover	3.65

Taxes

Income Tax	-13.97B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.84% in the last 52 weeks. The beta is 0.50, so AbbVie's price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	+1.84%
50-Day Moving Average	3,577.32
200-Day Moving Average	3,720.71
Relative Strength Index (RSI)	61.01
Average Volume (20 Days)	961

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.55

Income Statement

In the last 12 months, AbbVie had revenue of MXN 1.10 trillion and earned 70.21 billion in profits. Earnings per share was 39.61.

Revenue	1.10T
Gross Profit	783.67B
Operating Income	373.47B
Pretax Income	57.14B
Net Income	70.21B
EBITDA	529.43B
EBIT	373.47B
Earnings Per Share (EPS)	39.61

Balance Sheet

The company has 121.96 billion in cash and 1.33 trillion in debt, giving a net cash position of -1,209.15 billion.

Cash & Cash Equivalents	121.96B
Total Debt	1.33T
Net Cash	-1,209.15B
Net Cash Per Share	n/a
Equity (Book Value)	-2.60B
Book Value Per Share	-1.95
Working Capital	-198.12B

Cash Flow

In the last 12 months, operating cash flow was 363.64 billion and capital expenditures -19.69 billion, giving a free cash flow of 343.95 billion.

Operating Cash Flow	363.64B
Capital Expenditures	-19.69B
Free Cash Flow	343.95B
FCF Per Share	n/a

Margins

Gross margin is 71.25%, with operating and profit margins of 33.95% and 6.45%.

Gross Margin	71.25%
Operating Margin	33.95%
Pretax Margin	5.19%
Profit Margin	6.45%
EBITDA Margin	48.13%
EBIT Margin	33.95%
FCF Margin	31.27%

Dividends & Yields

This stock pays an annual dividend of 127.30, which amounts to a dividend yield of 3.44%.

Dividend Per Share	127.30
Dividend Yield	3.44%
Dividend Growth (YoY)	20.43%
Years of Dividend Growth	1
Payout Ratio	321.43%
Buyback Yield	-0.03%
Shareholder Yield	3.41%
Earnings Yield	1.08%
FCF Yield	5.30%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 2.14 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.14
Piotroski F-Score	6